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Abstract
Background: Bone morphogenetic proteins regulate multiple processes in embryonic development, including early
dorso-ventral patterning and neural crest development. BMPs activate heteromeric receptor complexes consisting
of type I and type II receptor-serine/threonine kinases. BMP receptors Ia and Ib, also known as ALK3 and ALK6
respectively, are the most common type I receptors that likely mediate most BMP signaling events. Since early
expression patterns and functions in Xenopus laevis development have not been described, we have addressed
these questions in the present study.
Results: Here we have analyzed the temporal and spatial expression patterns of ALK3 and ALK6; we have also
carried out loss-of-function studies to define the function of these receptors in early Xenopus development. We
detected both redundant and non-redundant roles of ALK3 and ALK6 in dorso-ventral patterning. From late
gastrula stages onwards, their expression patterns diverged, which correlated with a specific, non-redundant
requirement of ALK6 in post-gastrula neural crest cells. ALK6 was essential for induction of neural crest cell fate
and further development of the neural crest and its derivatives.
Conclusions: ALK3 and ALK6 both contribute to the gene regulatory network that regulates dorso-ventral
patterning; they play partially overlapping and partially non-redundant roles in this process. ALK3 and ALK6 are
independently required for the spatially restricted activation of BMP signaling and msx2 upregulation at the neural
plate border, whereas in post-gastrula development ALK6 exerts a highly specific, conserved function in neural crest
development.
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Background
Bone morphogenetic proteins (BMPs) are a subfamily of
the TGFβ superfamily of secreted growth factors. Origin-
ally identified as regulators of bone formation [1–3] it is
now well established that BMPs are major factors of
dorso-ventral axis determination from Drosophila to
mammals [4–10]. During later development, BMPs
contribute to neural patterning and differentiation, the
induction of the vertebrate neural crest and placodes
and the development of the lens and inner ear [11–18].
BMP signaling is also required in eye development, car-
diac, kidney, and thymus organogenesis, germ cell differ-
entiation, and hematopoiesis [19–25]. In addition, its roles
in chondrogenesis, skeletal and limb development and
patterning are well documented [reviewed in 26–29].
BMP ligands bind to and activate a tetrameric receptor
complex composed of two type I and two type II recep-
tors [30–34]. Type I receptors are also referred to as
Activin-receptor Like Kinase (ALK). The human genome
contains 35 Transforming Growth Factor beta (TGFβ) fam-
ily genes, but only seven genes encoding for type I, and five
genes encoding for type II receptors. BMP receptors are
single-pass transmembrane proteins and possess a serine/
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threonine kinase domain in their intracellular domains
[35–40]. BMP ligands activate only a subset of these recep-
tors, namely BMP Receptor II (BMPRII) or Activin
Receptor IIB (ActRIIB) as type II receptors and BMP
Receptor Ia (BMPRIa/ALK3), BMP Receptor Ib (BMPRIb/
ALK6) or Activin Receptor Ia (ActRIa/ALK2) as type I re-
ceptors; in some cases, the Activin Receptor Ib (ActRIb/
ALK4) is also activated [41, 42]. Upon ligand binding the
type II receptors phosphorylate and activate the type I
receptors. In the canonical TGFβ signal transduction path-
way, activated type I receptors phosphorylate a receptor
substrate protein of the Mad/Smad family of transcriptional
regulators (R-Smads). Phosphorylated Smads bind another
Smad family member, the so-called Co-Smad, which itself
is not a substrate of the type I receptor; they are then
imported into the nucleus. Nuclear Smads associate with
additional transcriptional regulators and cofactors, and
regulate transcription of their target genes [reviewed in 43].
R-Smads are subdivided into two groups, the Smad 2/3 and
the Smad 1/5/8 groups, which mediate signaling by TGFβ,
Activin and Nodal ligands or by BMPs, respectively
[reviewed in 44].
In Xenopus laevis, BMP4 is expressed in a semicircle
at the ventral side of the embryo at early gastrula stage
10.5 and plays a major role in the induction of ventral
cell fates [7, 45]. Ventral BMP activity is antagonized by
secreted BMP antagonists such as chordin or noggin
that are derived from the organizer, thereby creating a
BMP gradient that patterns the dorso-ventral axis
[reviewed in 46]. Similar to ventral BMP4 expression in
Xenopus, graded expression of BMP ligands is involved
in dorso-ventral patterning in zebrafish [47]. BMP7,
BMP2 and Anti Dorsalizing Morphogenetic Protein
(ADMP) also contribute to ventral cell fate specification
in Xenopus embryos, although these BMP ligands are
expressed without dorso-ventral bias or even exclusively
dorsal in the Spemann’s organizer [6, 48–51]. In post-
gastrula embryos, BMP ligands are expressed in specific,
spatially restricted patterns that reflect their role in the de-
velopment of the respective tissues and organs. [6, 45, 48].
Similarly, in tadpole embryos expression of BMPR1a is
found in the eye, otic vesicle, kidney, branchial arches,
foregut and intersomitic tissue. BMPR1b expression is also
detected in the head but not in trunk tissue [52–54].
By contrast, little is known about the expression pat-
terns of BMP receptors in early Xenopus embryos. Here,
we have analyzed the expression pattern and function of
BMPRIa/ALK3 and BMPRIb/ALK6 in early Xenopus
development. We observed only partial functional re-
dundancy of the receptors in dorso-ventral patterning.
In late-gastrula and neurula stages the expression pat-
terns and function diverge markedly. In particular, we
identified a specific, non-redundant function of ALK6 in
neural crest development.
Results and discussion
Expression of bmprIa/alk3 and bmprIb/alk6 during
Xenopus development
We have cloned the full-length coding sequence of Xen-
opus laevis BMP-receptor Ia (BMPRIa/ALK3) and BMP-
receptor Ib (BMPRIb/ALK6; see Additional file 1: Figure
S1 for alignment of the ALK6 sequence and phylogenetic
analysis, phylogeny data is also available at http://purl.org/
phylo/treebase/phylows/study/TB2:S18663). First, we com-
pared their temporal and spatial expression pattern in early
Xenopus embryos. In whole-mount in situ hybridization,
alk3 RNA was detected in the animal hemisphere of early
to late-blastula and early gastrula stage embryos. Its distri-
bution expanded vegetally, but remained excluded from the
vegetal pole, in mid-gastrula stage embryos (Fig. 1a). Not-
ably, no dorso-ventral bias was observed. ALK6 RNA was
not detected in blastula stages and only very weakly in early
and mid-gastrula stage embryos. By late-gastrula, at Nieuw-
koop and Faber stage 12 (NF stage 12, [55]) the spatial ex-
pression patterns of alk3 and alk6 became divergent. While
alk3 expression remained ubiquitious, alk6 was specifically
upregulated in the anterior neural plate. This temporal and
spatial expression pattern is conserved between Xenopus
and zebrafish gastrulae [56]. In the mouse, alk3 is also ubi-
quitously expressed until E9.5, whereas alk6 was detected
only from E9.5 onwards and showed a more restricted ex-
pression pattern when compared to alk3 [57].
In neurula stages, alk3 was still ubiquitously expressed,
but we observed a slightly more intense staining for alk3
at the neural plate border in NF stage 13 embryos and in
the anterior neural plate in NF stage 16 embryos. Again,
alk6 showed a strikingly different expression pattern dur-
ing neurulation with the strongest expression at the neural
plate border, in the anterior neural plate and in the pro-
spective neural crest (Fig. 1a). The neural crest is induced
at the neural plate border by a combination of intermedi-
ate levels of BMP signaling, WNT and FGF signaling
[reviewed in 14, 58, 59]. Among the gene network that de-
fines the neural crest, a subset of genes has been identified
as direct targets of the BMP pathway via Smads, including
the neural plate border specifying gene msx2 [60] and slug
[61]. Therefore the restricted expression pattern of ALK6
in the prospective neural crest suggests a specific role of
alk6 in neural crest specification and development.
In early tadpole stages, expression of alk3 was detected
in the brain and the eye, corresponding to the upregula-
tion in the anterior neural plate at NF stage 16. By con-
trast, at NF stage 23, alk6 was strongly expressed in the
brain, the ventral part of the eye and in the migrating
neural crest cells (Fig. 1a). In later tadpole stages we ob-
served expression of both genes in the brain, the eye, the
otic vesicle and the branchial arches, alk3 transcripts
were additionally detected in the heart, in intersomitic
tissue and the pronephros (Additional file 2: Figure S2).
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Alk6 was detected in the brain, eye, otic vesicle and
branchial arches, although in a more spatially restricted
pattern than alk3. In contrast to an earlier report
[52], we also detected alk6 expression in the notochord
(Additional file 2: Figure S2). These late expression pat-
terns mostly recapitulate tadpole expression of both type I
BMP receptors, as reported in other studies [52–54]. In
addition, the tadpole expression showed considerable
overlap with the expression of BMPRII [52, 62].
The increased expression of alk6 from late-gastrula
onwards, which was detected by in situ hybridization
(Fig. 1a), correlated well with the expression levels of
alk3 and alk6 determined by Real-Time RT-PCR
(Fig. 1b). Expression levels of alk3 decreased by 50 %
from NF stage 9 to NF stage 12 and then remained con-
stant until stage 17. By contrast, alk6 levels were 6 to
10-fold lower than alk3 from NF stage 9 to 11 and
showed a marked increase from NF stage 12 to 17,
Fig. 1 Expression patterns of alk3 and alk6 in early Xenopus laevis embryos. a Temporal and spatial expression patterns were determined by
whole-mount in situ hybridization at the indicated Nieuwkoop and Faber (NF) stages. b Expression of alk3 and alk6 was quantified by
Real-Time RT-PCR at the indicated stages; corresponding synthetic sequences were used a external standards for copy number determination.
The graph shows the copy number per embryo. c NF stage 10.5 embryos were bisected into dorsal and ventral halves and transcripts of the indicated
genes were detected by RT-PCR
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which resulted in an overall higher expression of alk6
when compared to alk3 at NF stage 17 (Fig. 1b). In
addition, RT-PCR analysis of semi-sectioned NF stage
10.5 embryos confirmed that alk3, alk6 and also the type
II receptor bmpr2 were expressed equally in the dorsal
and ventral halves (Fig. 1c). The same was true for the
activin receptors acvr1a/alk2, acvr1b/alk4 and acvr2 at
that stage (see Additional file 3: Figure S3).
The expression pattern of both alk3 and alk6 in pre-
and early gastrula stage embryos mirrors the unbiased
expression of BMPRII, BMP2 and BMP7 [6, 48, 62].
According to current knowledge, BMP2 and BMP7 and
the ventrally expressed BMP4 activate ventralizing BMP
signaling in early embryos. The dorso-ventral gradient of
BMP activity found in late blastula and early gastrula
Xenopus embryos [63] is shaped by ventrally expressed
positive regulators and BMP antagonists arising from
the dorsal organizer [reviewed in 46]. ALK3 and
ALK6 can act as receptors for BMP2, BMP4 and BMP7
[31, 32, 34, 64]; therefore, they are likely to mediate signal-
ing from all three ligands in early embryos.
To further elucidate the role of ALK3 and ALK6 we
have performed loss-of-function studies, focusing on
pre-gastrula development and characterizing a putative
specific role of ALK6 in the neural crest.
Knock-down of ALK3 and ALK6 results in partially
dorsalized embryos and additional specific phenotypes
To investigate the role of ALK3 and ALK6 in Xenopus
development, we have designed two translation-blocking
antisense Morpholino oligonucleotides (MOs), which
target non-overlapping sequences to knock-down each
protein (see also Additional file 4: Figure S4).
We injected ALK3 MO or ALK6 MO into both blasto-
meres of two-cell stage embryos and analyzed the result-
ing phenotypes at NF stage 40. First, we noticed that
knock-down of ALK6, particularly with ALK6 MO1,
caused a higher lethality of embryos when compared to
injection of ALK3 MO or control MO. At neurula
stages, 63 of 147 embryos out of three independent in-
jections with ALK6 MO1 survived whereas the numbers
of surviving embryos injected with ALK6 MO2 (98/134),
ALK3 MO1 (50/68) or ALK3 MO2 (97/122) were similar
to the control MO (92/137). At stage 40, the survival of
ALK6 MO1 and ALK6 MO2 injected embryos dropped
to 17 ± 13 (total 28/147 embryos) and 26 ± 13 % (total
42/134 embryos) respectively. By comparison, 50–56 %
embryos survived to stage 40 after injection of either
control MO, ALK3 MO1 or ALK3 MO2 (see also
Additional file 5: Figure S5).
Compared to control embryos (Fig. 2a), we observed a
range of phenotypes in the ALK3 or ALK6 morphant
embryos that reached tadpole stage. The weakest pheno-
types showed defects or partial loss of the ventral fin
(Fig. 2b) or defective pigmentation of the retina (Fig. 2c).
Stronger phenotypes included anterio-dorsalized em-
bryos with a progressive loss of ventral and posterior
structures (Fig. 2d). A subset of embryos showed in-
creased pigmentation of the head and less protruding
branchial arches, indicating that neural crest develop-
ment was affected (Fig. 2e). This phenotype was further
investigated and the results are shown in Figs. 5 and 6.
In addition, we observed complex phenotypes that affect
multiple structures (Fig. 2f ). Dorsalized and eye pheno-
types were most frequent in ALK3 morphant embryos
and no significant difference was observed between
ALK3 MO1 and ALK3 MO2. By contrast, knock-down
of ALK6 predominantly resulted in neural crest and pig-
mentation phenotypes. Although ALK6 MO2 appeared
to induce the phenotype with higher frequency, the
difference between ALK6 MO1 and ALK6 MO2 was
statistically not significant (Fig. 2g).
Homozygous deletion of alk3 in mice is early embry-
onic lethal [65]. Because morpholino oligonucleotide in-
jections in two-cell stage Xenopus embryos did not
deplete maternal protein, early lethality could not be ex-
pected. Homozygous alk6 knock-out mice are viable and
show moderate skeletal phenotypes [66]. The same study
suggested overlapping and redundant functions of ALK6
with other BMP receptors in mouse development. Since
the knock-down of ALK6 in Xenopus embryos resulted
in higher lethality and equally severe, albeit different
phenotypes as compared to the ALK3 knock-down, less
functional overlap of these two type 1 BMP receptors
could be assumed in Xenopus laevis.
Compound phenotypes in the surviving embryos were
expected, based on the complex expression patterns of
alk3 and alk6, and are comparable to phenotypes re-
ported for alk3 or alk6 loss-of-function in other verte-
brates. The role of both, ALK3 and ALK6 in the
development of the retina and lens is well established in
mouse and chick embryos [67–69]. In addition, defects
in brain and cranio-facial development as well as cartilage
and bone formation have been described [66, 68–70].
Likewise, we observed defects in the forebrain region,
smaller or absent eyes, which indicates that the develop-
mental functions of ALK3 and ALK6 are conserved within
vertebrates to a considerable extent. In addition, we ob-
served aberrant pigmentation and cranio-facial deform-
ation, indicating defects in the development of neural
crest derived melanocytes and cartilage [71]. Interestingly
and most notably, these phenotypes have been predomin-
antly observed in ALK6 morphants, supporting a specific
role of ALK6 in the development of the neural crest.
By contrast, we observed predominantly dorsalized phe-
notypes in ALK3-deficient embryos, which is in agree-
ment with blastula-stage expression of ALK3 and its
assumed role in early dorso-ventral patterning. Dorsalized
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Fig. 2 (See legend on next page.)
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phenotypes were also observed in ALK6 morphant
embryos although with lower frequency. The weakest
phenotype affecting ventral structures were defects in
the ventral fin, development of which depends on
BMP signaling. In zebrafish, inactivating or dominant-
negative mutations in BMP pathway genes, such as
bmp2b, smad5 or tolloid, result in the loss of the ven-
tral fin [72, 73]. In Xenopus, formation of the ventral fin is
similarly dependent on the ventral-most portion of the
mesoderm [74] which is specified by BMP signaling. Inter-
estingly, in zebrafish embryos, loss of the ventral fin has
been attributed to ALK8, which is most closely related to
ALK2 in other vertebrates [75, 76].
The higher frequency of dorsalized embryos in ALK3
morphant embryos, as compared to the ALK6 knock-
down was consistent with the expression of these type I
BMP receptors in pre-gastrula stage embryos. We
already detected alk3 RNA in early blastula-stage em-
bryos, whereas alk6 expression remained very low until
late gastrula (NF stage 12, Fig. 1). Together these results
support a major role of ALK3 and a minor contribution
of ALK6 in transducing ventralizing BMP signals in early
embryonic development.
Both type I BMP receptors contribute to dorso-ventral
patterning
In order to confirm that the observed dorsalization
phenotype in ALK3 and ALK6 morphant embryos was
related to a role in early dorso-ventral axis specifica-
tion, we next analyzed the influence of single and
double knock-downs on the expression of the dorsally
expressed organizer genes chordin, admp and goosecoid
(gsc) [49, 77, 78] as well as the ventral marker genes bmp4,
vent1 and sizzled [7, 79, 80] in early gastrula stage embryos.
The transcripts of chordin, admp and goosecoid were
exclusively detected in the dorsal halves of control em-
bryos (Fig. 3a). In ALK3 morphants, these dorsal genes
were also detected in the ventral halves of the embryos.
This effect was weakest for chordin, but clearly detect-
able for admp and goosecoid. By contrast, in ALK6 mor-
phant embryos the dorsal expression of admp and
goosecoid appeared to be slightly weaker and no expres-
sion was detected in the ventral half. In the double
morphant embryos, all three dorsal genes were clearly
detected in the ventral hemisphere (Fig. 3a). The inverse
was observed when we investigated expression levels of
the ventrally expressed genes bmp4, vent1 and sizzled.
Expression of bmp4 and vent1 was lower in the ventral
halves of ALK3, ALK6 or double morphant embryos.
When analyzing sizzled expression a detectably weaker
expression was only observed in double morphant em-
bryos, whereas single knock-down of either ALK3 or
ALK6 had no effect.
Although this experiment was not quantitative, it sug-
gested that knock-down of ALK3 and double knock-
down of ALK3 and ALK6 might result in an expansion
of the organizer domain into the ventral half of the
embryo, which would lead to a dorsalized phenotype.
Dorsalization was indeed observed predominantly in
ALK3 morphant embryos (see Fig. 2). Overall, these re-
sults indicated that both ALK3 and ALK6 play a role in
dorso-ventral patterning and contribute to the expres-
sion of ventral genes, as demonstrated by the pro-
nounced downregulation of bmp4, vent1 and sizzled in
double morphant embryos.
In order to further investigate the effect of ALK3 or
ALK6 depletion on the organizer, we performed whole
mount in situ hybridizations using a chordin antisense
probe in single-side injected embryos. Consistent with
the aforementioned RT-PCR results, the area containing
chordin-positive cells was enlarged by 50–70 % in ALK3
morphant embryos injected with either ALK3 MO 1 or
ALK3 MO 2, while the average staining intensity for
chordin relative to the expression area remained un-
changed (Fig. 3b and c). This expansion of the chordin-
expressing area was reverted by co-injection of alk3
RNA. By contrast, depletion of ALK6 did not signifi-
cantly affect the distribution of chordin-expression or
the relative staining intensity (Fig. 3b and c). Although
ALK3 knock-down significantly expanded the chordin-
positive area, this effect was mild when compared to the
overexpression of a dominant-negative mutant of ALK3
(dnALK3/tBR, [81, 82]). DnALK3 induced strongly ex-
panded and ectopic chordin expression in the majority
of embryos (Fig. 3d). By contrast, we did not observe ec-
topic chordin expression in ALK3 morphant embryos.
(See figure on previous page.)
Fig. 2 Phenotypes of ALK3 and ALK6 morphant embryos. Embryos were injected with 0.8 pmol antisense morpholino in both blastomeres
at the 2-cell stage as indicated and cultured till NF stage 41. a Normal NF stage 41 embryos after injection of an unrelated control Morpholino
oligonucleotide (control MO). b Embryos injected with either ALK3 or ALK6 translation blocking Morpholino oligonucleotides (ALK3 MO and ALK6 MO
respectively) showing defects in the development of ventral fins. c In the retina of a subset of either ALK3 MO or ALK6 MO injected embryos un- or less
pigmented patches were observed. d Dorsalized ALK3 morphant embryo. e ALK6 morphant embryo showing increased pigmentation of the head
and narrower gills. f In most cases ALK3 or ALK6 morphant embryos exhibited complex phenotypes with defects in the ventral fin, retina pigmentation,
smaller or absent eyes, aberrant pigmentation and loss of cranial cartilage. Black arrowheads indicate eye phenotypes, white arrows missing ventral
structures and black arrows mark the cranial cartilage. g Phenotype frequencies from at least three independent experiments are summarized in the
graph. Differences between indicated groups were analyzed using the Χ2 test. Statistically significant deviations (p-value < 0.01) are indicated by double
asterisks; n.s.: not significant
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This discrepancy is likely due to the presence of ma-
ternal protein and possibly a contribution of add-
itional type I receptors, such as ALK2 or ALK4 [41,
42] to the early BMP signal. Both ALK2 and ALK4
are expressed in early Xenopus embryos (see Add-
itional file 3: Figure S3) and their activation by BMP
ligands would also be inhibited by dnALK3 but not
by ALK3 knock-down.
We next confirmed that the upregulation of dorsal
genes in ALK3 morphant embryos observed at early gas-
trula stages indeed results in an expansion of dorsal tis-
sues; therefore, we analyzed the influence of ALK3
knock-down on neural induction. Consistent with our
previous results, single knock-down of ALK3 was suffi-
cient to induce mild broadening of the neural plate and
expression of the pan-neural marker sox2 (Fig. 4a, b).
Fig. 3 ALK3 and ALK6 are required for dorso-ventral patterning. a 2-cell-stage embryos were injected with 1.6 pmol control MO, ALK3 MO or
ALK6 MO in both blastomeres as indicated, cultured till stage 10.5 and bisected into dorsal (d) and ventral (v) halves. Expression of the organizer
genes chordin (chd), admp and goosecoid (gsc) and the ventral genes bmp4, vent1 and sizzled was analyzed by RT-PCR. The images show one set
out of three independent experiments. (b-g) Embryos were injected with Fluorescein-labeled dextran as lineage tracer and antisense Morpholino
oligonucleotides as indicated into one blastomere at the 2-cell-stage. For rescue experiments, 50 pg of alk3 RNA or alk6 RNA were co-injected.
The embryos were cultured till stage 10.5 and chordin expression was visualized by whole-mount in situ hybridization. b Representative examples
of phenotypes injected as indicated are shown. Asterisks indicate the injected side, dashed lines mark the dorsal midline as determined by the
lineage tracer. c The chordin-positive area and staining intensity have been measured on the injected and uninjected side of each embryo. The
graph displays the average ratio of area size between injected and uninjected side (+SEM) as well as the mean intensity/area (+SEM) from three
independent experiments. Differences of area ratios between injection groups have been analyzed using a separate variance t-test and statistically
significant deviations are indicated by double asterisks (p-value < 0.01); n.s.: not significant. The average intensity/area did not change significantly.
d For comparison, an embryo injected with 50 pg RNA encoding dnALK3 is shown. In 10 out of 38 embryos dnALK3 induced strongly expanded
or ectopic chordin expression
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Fig. 4 Ectopic ALK6 can substitute ALK3 knock-down in dorso-ventral patterning. Embryos were injected laterally in one dorsal blastomere at the
4-cell stage with 0.8 pg of ALK3 or ALK6 MOs and, for rescue experiments, co-injected with 50 pg of alk3 RNA or alk6 RNA. A lacZ plasmid was
co-injected to identify the injected side, embryos were cultured till stage 18 and stained for LacZ. The neuroectoderm was visualized by in situ
hybridization against the pan-neural marker gene sox2. Embryos were categorized according to expanded or reduced sox2
expression and differences between indicated groups were analyzed using the Χ2 test. Statistically significant deviations (p-value < 0.01) are indicated
by double asterisks; n.s.: not significant. a Representative images of ALK3 morphant embryos and the corresponding rescue experiments are shown.
Embryos were injected as indicated; asterisks indicate the injected side. b Results from at least three independent experiments are summarized in the
graph. c Representative images of ALK6 morphant embryos and the corresponding rescue experiments are shown. Embryos were injected
as indicated; asterisks indicate the injected side. d Results from at least three independent experiments are summarized in the graph
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This ALK3 MO 1 phenotype was rescued by co-
injection of either morpholino-insensitve ALK3 RNA or
ALK6 RNA, demonstrating the specificity of this knock-
down phenotype and functional redundancy of ALK3
and ALK6 (see also Additional file 7: Figure S7). Bring-
ing back ALK3 also resulted in a downregulation of sox2
in roughly 15 % of the embryos, which indicated an
over-compensation of the morphant phenotype. Com-
parable results were obtained using ALK3 MO 2; the
size of the sox2-positive area was increased by 12.5 ±
2.6 % by injection of ALK3 MO 1 and by 11 ± 3.1 % by
ALK3 MO 2 respectively. However, in embryos injected
with ALK3 MO 2, broadening of the neural plate oc-
curred more frequently as compared to ALK3 MO 1
(Fig. 4a, b). Double knock-down of ALK3 and ALK6 did
not further increase the percentage of embryos showing
an enlarged sox2-positive area.
We repeated this experiment and targeted the injections
to one animal blastomere of eight-cell stage embryos,
which should limit the knock-down to the ectoderm and
avoid interfering with organizer formation. The outcome
was very similar to the results obtained after injection at
the four-cell stage (Additional file 6: Figure S6). Ecto-
dermal knock-down of ALK3 by ALK3 MO 1 or ALK3
MO 2 resulted in an increase of the sox2-positive area
by 14 ± 3.1 and 18 ± 6.9 % respectively. Again, the
phenotype was rescued by both alk3 RNA and alk6
RNA. These results indicated that in addition to its role
in early dorso-ventral specification, ALK3 also influ-
enced ectodermal patterning.
Overall, we have demonstrated a role for ALK3 in the
specification of ventral cells fates and ectodermal pat-
terning. However, we observed only moderate dorsaliza-
tion even after ALK3/6 double knock-down. Our data
are consistent with a comparable study in zebrafish in
which the double knock-down of ALK3 and ALK6
resulted in only weakly dorsalized phenotypes [56]. Mor-
pholino mediated knock-down did not affect maternal
protein, which is possibly a cause for these results. In
addition, triple knock-down of the BMP ligands BMP2,
BMP4 and BMP7 induced only moderate dorsalization
with decreased sizzled expression and no effect on chor-
din [50]. The same group showed that strong dorsaliza-
tion required additional knock-down of ADMP [51].
Knock-down of ALK3 or ALK6 is not expected to affect
ADMP activity, because ADMP does not bind to ALK3
or ALK6, but to ALK2 [51]. ALK3 and ALK6 have been
identified as receptors for BMP2, BMP4 and BMP7 in
multiple studies [34, 64, 83]. Both ALK3 and ALK6 form
receptor complexes with BMPRII [31, 36] and BMP2 as
well as BMP7 signal via heteromeric receptor com-
plexes comprising different type I receptors in dorso-
ventral patterning in zebrafish [84]. Therefore the
highly similar effect of BMP2/4/7 knock-down [50] and
ALK3/6 knockdown (this study) support the conclusion
that ALK3 and ALK6 predominantly act as receptors
for BMP2, BMP4 and BMP7 ligands in early dorso-
ventral patterning.
Moreover, we observed that ALK3 knock-down is suf-
ficient to expand the expression territory of organizer
genes in early gastrula stage embryos, indicating that
ALK3 is the dominant type I receptor in the BMP activ-
ity gradient that antagonizes expression of organizer
genes. Such a bigger role for ALK3 as compared to
ALK6 is in agreement with higher expression levels of
ALK3 in pre- and early gastrula stages.
We also analyzed sox2 expression in ALK6 morphant
embryos. Interestingly, injection of ALK6 MO 1 or
ALK6 MO 2 into one dorsal blastomere of four-cell
stage embryos resulted in an anterior downregulation of
sox2 on the injected side at neurula stages (Fig. 4c and
d). The size of the sox2-positive area was reduced by 10
± 2.1 and 17 ± 3.1 % in embryos injected with ALK6 MO
1 and ALK6 MO 2, respectively. This phenotype was
rescued by co-injection of either alk3 RNA or alk6
RNA (see also Additional file 7: Figure S7), which is
contradictory to the results shown above that demon-
strate a role of ALK3 in ventral specification and antag-
onizing neural induction. An ALK3 gain-of-function
would be expected to inhibit neural induction and thus
reduce the size of the sox2 expression area. In addition,
these results overall are contradictory to the theory that
BMP activity antagonizes neural induction [6]. More-
over, we did not observe a significant effect of ALK6
knock-down on the size of the organizer as determined
by the chordin-positive area at early gastrula (Fig. 3b and
c). Taking into account that alk6 expression is very low
during gastrulation but upregulated in the anterior
neural plate and neural plate border at late gastrula and
early neurula stages, this decrease of sox2 is possibly not
caused by alterations of the early BMP gradient. Instead,
a role of ALK6 in the development or maintenance of
anterior neural tissue after neural induction might be
hypothesized, however, the nature and mechanism of
such a putative function remains to be investigated.
ALK6 is required for neural crest specification
The ALK6 morphant phenotype with embryos showing
a marked increase of pigment cells, and in some cases a
dramatic loss of cranial cartilage, indicated defects in
neural crest development (see Fig. 2). Since ALK6 is spe-
cifically upregulated in the neural crest during neurulation
(Fig. 1a), we analyzed its role in neural crest development
in more detail.
ALK6 morphant embryos frequently showed an in-
creased number of melanocytes in the dorsal head region,
which was in most cases accompanied by deformed bran-
chial arches (Fig. 1). Closer examination of these embryos
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Fig. 5 ALK6 is required for neural crest development. a When compared to control MO injected embryos, ALK6 morphant embryos showed increased
pigmentation of the head (arrow), ectopic melanocytes in the dorsal fin (arrowheads) and narrower heads reflected by less lateral protrusion of the gills
and smaller distance between the eyes (double arrow). b Cranial cartilage from embryos injected as indicated was stained with Alcian Blue dye. Cartilage
from ALK6 morphant embryos generally showed weaker staining, was smaller (double arrows in B’, B” and B”’) and showed partial or complete loss of
cartilage elements (arrowheads in B’, B” and B”’) of the gills (g) or ceratohyal cartilage (c). The images in A and B show representative examples from one
out of three independent experiments. c Embryos were injected with 1.6 pmol morpholino in one animal-dorsal blastomere at the 8-cell stage as
indicated. A lacZ plasmid was co-injected to identify the injected side, embryos were cultured till stage 13 and stained for LacZ. Expression of msx2 was
analyzed by whole-mount in situ hybridization. Representative images of embryos injected as indicated are shown. Asterisks indicate the injected side.
The results from three independent experiments are summarized in the graph (d). Active BMP signaling at the neural plate border was shown by
whole-mount immunostaining for phosphorylated Smad 1/5/8 (pSmad 1/5/8). e The graph shows a summary of pSmad1/5/8 staining results from two
independent experiments. In (f) representative images of embryos injected with control MO, ALK3 MO 1 or ALK6 MO 1 are shown. Embryos were catego-
rized according to decreased or enhanced msx2 expression or pSmad 1/5/8 staining respectively and differences between indicated groups were ana-
lyzed using the Χ2 test. Statistically significant deviations (p-value < 0.01) are indicated by double asterisks; n.s.: not significant
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revealed aberrant localization of melanocytes in both
ALK6 MO 1 and ALK6 MO 2 injected embryos. Many
melanocytes were found in the dorsal head region,
whereas the flank in most embryos was less pigmented. In
addition, we observed ectopic melanocytes in the dorsal
fin (Fig. 5a), indicating aberrant specification or migration
of neural crest derived melanocyte precursors.
Embryos showing aberrant pigmentation were sub-
jected to Alcian Blue staining of the cranial cartilage. All
ALK6 morphant embryos showed fainter cartilage stain-
ing, indicating incomplete cartilage differentiation. In
addition, we observed a range of defects in the cranial
cartilage. In milder cases, parts of the gills were missing
and the ceratohyal cartilage was smaller or deformed;
overall, the cartilage elements present were only faintly
stained. In the most severe cases, only tiny, unstructured
remnants of cartilage were found (Fig. 5b). The require-
ment of ALK6 in chondrogenic differentiation of the
cranial cartilage, as indicated by reduced Alcian Blue
staining, is consistent with the role of ALK6 in cartil-
age and bone formation in the mouse [66, 85]. More-
over, the partial or complete loss of cranial cartilage
elements (Fig. 5b) together with the prominent ex-
pression of alk6 in pre-migratory and migrating
neural crest cells (Fig. 1a) indicated an additional role
in early neural crest development.
Neural crest development begins in the dorso-lateral
marginal zone of early gastrula embryos in Xenopus. In
this region attenuated BMP activity combined with active
Wnt/β-Catenin signaling specifies neural crest precursors
[14, 86]. After gastrulation neural crest precursors are
located at the neural plate border and identified by the ex-
pression of a specific set of transcription factors, including
msx1 and msx2, that induce further neural crest develop-
ment [59, reviewed in 87].
To address the question of whether the neural crest
is not induced in ALK6 morphants or if neural crest
cells get lost during pre-migratory development, we
analyzed the expression of msx2 in the neural plate
border at late gastrula stages. Both ALK3 and ALK6
loss-of-function resulted in a downregulation of msx2,
although 23 % of ALK3 morphant embryos showed
an increase of msx2 (Fig. 5c and d). In the ALK6
morphants, no increased msx2 expression was ob-
served, but more than 70 % of embryos showed a de-
crease or loss of msx2 expression (Fig. 5d), thus
demonstrating further that particularly ALK6 plays a
crucial role in neural crest development. Interestingly,
the frequency of increased and decreased msx2 ex-
pression in double morphant embryos represented the
average of phenotype frequencies that were observed
in the single knock-downs (Fig. 5d), indicating that
ALK3 and ALK6 affect msx2 expression independ-
ently of each other.
It has been shown that reducing BMP activity in
blastula or gastrula stages results in a shift and
expansion of the neural plate border area as well as
upregulation of neural crest markers [88]. Such
expansion of the msx2 expression area was only
observed in approximately one quarter of ALK3 mor-
phant embryos, which is consistent with the role of
ALK3 in dorso-ventral patterning discussed above. On
the other hand, msx1 and msx2 are regulated by BMP
signaling, and msx2 has been identified as a direct
BMP target [13, 60, 89]. The observed downregulation
of msx2 in ALK3 and ALK6 morphant embryos coin-
cided with the upregulation of both type I receptors
at the neural plate border in late gastrulation (see
Fig. 1a); together, these observations strongly suggested a
role for ALK3 and ALK6 in this Smad-dependent tran-
scriptional regulation.
To confirm that both receptors signal to Smad at the
neural plate border, we probed NF stage 13 embryos for
the presence of active phosphorylated Smad1/5/8
(pSmad1/5/8) using a phospho-specific antibody. We
observed a narrow stripe of pSmad1/5/8 positive cells
along the neural plate border. This local activation of
BMP signaling was detectable from NF stage 12.5 on-
ward, again coinciding with the upregulation of ALK6 as
well as ALK3, albeit to a lesser extent, at the neural plate
border. After injection of ALK3 MO, we detected a de-
crease of pSmad 1/5/8 at the neural plate border in ap-
proximately 50 % of the embryos. The effect was again
more pronounced in ALK6 morphants (Fig. 5e and f),
which showed a reduction of pSmad 1/5/8 in over 70 %
of the embryos. This result demonstrated that both
ALK3 and ALK6 activate Smad in neural plate border
cells. Moreover, pSmad data were highly similar to the
msx2 expression data (Fig. 5d and f), which is consistent
with msx2 being a direct target gene of BMP signaling
[60]. Therefore it is conceivable that both ALK3 and
ALK6 contribute to the activation of Smad at the neural
plate border, thereby upregulating BMP-responsive
neural plate border genes such as msx1 and msx2. Ac-
cording to current models of neural crest development
in Xenopus, neural crest precursors are first specified at
early gastrula stages by the combined input of low BMP
and low Wnt/β-Catenin signaling [14, 90]. During gas-
trulation, cells located lateral of the future neural plate
receive Wnt/β-Catenin, FGF, Notch and BMP signals
that induce the expression of neural plate border specify-
ing or pre-patterning genes such as gbx2, pax3, zic1, msx1
and the BMP target gene msx2 [13, 58–60, 87, 91–93].
These neural plate border factors govern further induction
of neural crest cells and the expression of genes required
for proliferation, survival and migration of the neural
crest, including ap2α, foxd3, sox8, sox9, sox10, slug, snail
and twist [58, reviewed in: 59, 87, 94–99].
Schille et al. BMC Developmental Biology  (2016) 16:1 Page 11 of 17
Consistent with a role of ALK6 in neural plate border
specification, sox8 was severely downregulated in ALK6
depleted embryos at neurula stages (Fig. 6a and b). We
observed decreased expression of sox8 in approximately
50 % of all embryos injected with ALK6 MO2. Co-
injection of MO-insensitive alk6 RNA fully rescued sox8
expression and further supported a role of ALK6 in neural
crest induction (Fig. 6a and b). Interestingly, the frequency
of the neural crest induction phenotype dropped from over
70 % of embryos showing decreased msx2 expression at
NF stage 13 to 50 % embryos with decreased sox8 expres-
sion at NF stage 18. This decline of phenotype frequency
indicated a partial regeneration of neural crest cells; such
regenerative potential has also been observed in chick
Fig. 6 Analysis of sox8 and twist expression in ALK6 morphant embryos. Embryos were injected with 1.6 pmol morpholino targeted animally in
one dorsal blastomere at the 4-cell stage. A lacZ plasmid was co-injected to identify the injected side, embryos were cultured till stage 18 or 24
and stained for LacZ. The neural crest was visualized by in situ hybridization against sox8 at stage 18 and against twist at stage 24. Differences
between indicated groups were analyzed using the Χ2 test. Statistically significant deviations (p-value < 0.01) are indicated by double asterisks; n.s.:
not significant. a Representative images of embryos hybridized against sox8 and injected as indicated are shown. The ALK6 MO phenotype was
rescued by co-injection of 50 pg alk6 RNA. Asterisks indicate the injected side. The results from three independent experiments are summarized
in the graph (b). c Representative images of the uninjected and injected sides of embryos of stage 24 embryos hybridized against twist are
shown. Embryos were injected with 1.6 pmol of ALK6 MO 1; for rescue experiments 25 pg of alk3 plasmid DNA or alk6 plasmid DNA were
co-injected. The results from three independent experiments are summarized in the graph (d)
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embryos after removal of neural crest cells [100]. In
addition, proliferation of pre-migratory neural crest cells
could contribute to the observed partial recovery of the
neural crest population between NF stage 13 and NF stage
18.
We next visualized the migrating neural crest in NF
stage 26 embryos by in situ hybridization for twist ex-
pression. ALK6 MO 1 injection induced a downregula-
tion of twist in 36 % of the embryos (Fig. 6c and d). This
further decline in frequency of the “decreased” neural
crest marker gene phenotype supports the assumption
that the neural crest population is partially recovering in
ALK6 morphant embryos. By contrast, single knock-
down of ALK3 resulted in less than 15 % of induction
defects (Fig. 6d) as compared to 45 % at NF stage 13
(Fig. 5d). This might simply indicate a delayed specifica-
tion of the neural plate border in ALK3 depleted em-
bryos, where ALK3 function could be compensated
albeit belatedly by redundant proteins, such as ALK6,
during later neural crest development. Notably, ALK6
knock-down was not fully compensated until tadpole
stages, which suggests a partially non-redundant role of
ALK6 in post-induction neural crest development. Such
an additional role of ALK6 is further supported by the
occurrence of impaired neural crest migration in 24 % of
ALK6 morphant embryos that was not observed in
ALK3 MO-injected embryos (Fig. 6c and d). However, it
cannot be concluded whether ALK6 itself plays a direct
role in neural crest migration or if the observed migra-
tion defects are secondary effects of impaired neural
crest specification in these embryos.
To rescue the ALK6 MO phenotype without interfering
with dorso-ventral patterning, we co-injected plasmids en-
coding ALK3 or ALK6 that are expressed only when zyg-
otic transcription is initiated after the mid-blastula
transition. The neural crest phenotype in ALK6 mor-
phants was not rescued by co-injection of alk3 plasmid
DNA, although an upregulation of twist was observed in a
low percentage of embryos when ALK3 was overexpressed
in the ALK6 morphant background (Fig. 6c and d). By
contrast, ALK6 MO was fully rescued by co-injection of
alk6 plasmid DNA (Fig. 6c and d), which again confirmed
a specific, non-redundant function of ALK6 in the neural
crest. Injection of plasmid DNA typically results in a mo-
saic expression of the gene. Assuming that the ALK6
knock-down phenotype could be compensated partially by
expansion of the residual neural crest progenitor popula-
tion, the plasmid would restore ALK6 in a subset of cells
and thereby increase this progenitor population sufficiently
to allow full regeneration of the neural crest. Notably,
maintenance of the neural crest fate during neurulation re-
quires secreted growth factors that are derived from adja-
cent tissues including BMPs from the non-neural
ectoderm and Wnt signals from the underlying paraxial
mesoderm [14, 61, 90]. Therefore, ALK6 function could
also be indirect via a secreted factor. In this case, restoring
ALK6 function in a mosaic pattern by plasmid DNA injec-
tion would also be sufficient to fully rescue the phenotype
because the secreted protein would act on all receiving
cells within its range of action.
Altogether, these results demonstrate a role of ALK3
and ALK6 in the early specification of neural crest pre-
cursors whereas exclusively ALK6 is required for neural
crest maintenance and migration in post-gastrula stages.
In this study, we have demonstrated that ALK3 and
ALK6 are required for early neural crest precursor speci-
fication during gastrulation, although likely to be inde-
pendent from each other. Consistent with a role of both
receptors in early BMP-dependent dorso-ventral pat-
terning of the embryo as shown and discussed above, it
is conceivable that ALK3 and ALK6 signaling first con-
tributes to positioning of the neural plate border and
then mediates the moderate activation of BMP signaling
in cells lateral of the neural plate that leads to the ex-
pression of neural plate border genes such as msx2. At
late gastrula and early neurula stages, ALK3 is expressed
in this region, and ALK6 expression is upregulated in
the anterior neural plate and at the neural plate border
from NF stage 12 onwards. This locally elevated expres-
sion correlates temporally and spatially with a local acti-
vation of Smad, and we have demonstrated that once
again both type I receptors play a role in this process.
However, we also observed that specifically ALK6, but
not ALK3, plays an essential role in post-gastrula neural
crest development.
The transition from cell fate specification at the neural
plate border to maintenance of neural crest identity and
further development takes place in early neurula stages.
Based on expression patterns and functional analyses,
we propose that a switch from an early, cooperative and
redundant function of ALK3 and ALK6 in neural crest
specification towards a highly specific function of ALK6
in neural crest maintenance and migration takes place
during this phase. This could be related to a change in
BMP ligands that are available. During early embryonic
development, BMP2, BMP4 and BMP7 are expressed
and required for dorso-ventral patterning, and all three
ligands can signal via ALK3 or ALK6 or heteromeric re-
ceptor complexes [34, 64, 84]. A recent study in zebra-
fish showed that in early neurulation two distinct
domains of active BMP signaling demarcate the borders
between epidermis, pre-placodal ectoderm and the
neural crest; it also showed that this local BMP activa-
tion depends on GDF6, also known as BMP13 [101]. In
Xenopus, gdf6 is expressed in a single stripe at the neural
plate border from late gastrula stage until late neurula
stages [102], overlapping with ALK6 expression as
shown in Fig. 1a. Consistently, we detected only one
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stripe of pSmad1/5/8 along the neural plate border at
NF stage 13. Despite this difference, which might be due
to temporal divergence of neural crest and placodal spe-
cification between zebrafish and Xenopus, it is likely that
GDF6 mediated local activation of BMP signaling in the
neural crest is conserved in both species. GDF6 signals
via ALK3 and ALK6 but displays a preference towards
ALK6 [42]. We have demonstrated herein that in
Xenopus the transition from cell fate specification to
maintenance of neural crest identity is accompanied
by a shift in type I receptor requirement towards
ALK6. Therefore we propose that post-gastrula neural
crest development specifically requires ALK6 to mediate
GDF6 signaling, a hypothesis that needs to be further in-
vestigated in the future.
Conclusion
Here we have demonstrated overlapping and non-
redundant functions of the type I BMP receptors ALK3
and ALK6 in early Xenopus development. Both contrib-
ute to BMP dependent ventral identity, but ALK6 is add-
itionally required for gene expression and size of the
dorsal organizer in Xenopus embryos. These results
show that despite overlapping expression patterns and
activation of the same Smad signaling pathway, ALK3
and ALK6 exert temporally and spatially specific, diver-
ging functions; indeed, they are important factors in the
regulatory network that controls patterning of early em-
bryos and the ectoderm.
In addition, we have demonstrated a highly specific ex-
pression of ALK6 in the neural crest and an exclusive re-
quirement of ALK6 in neural crest induction and
development. ALK6 likely acts a receptor for GDF6 in
the neural crest and mediates neural crest development
via an evolutionary conserved mechanism in the transi-
tion from neural crest specification to maintenance and
further determination of cell fate.
Methods
Morpholinos, plasmids and antibodies
ALK3 and ALK6 Morpholinos (ALK3 MO 1: TTCTTG
AAGAAGTATGCTCGCCTTT; ALK3 MO 2: CAACCA
ACCCATCCCTTGTGCCGGA; ALK6 MO 1: ACTCCA
CTCTCTGTTCCTCCTTTGT; ALK6 MO 2: TTGGGA
ACTTGTCAAACAACCGGCC) and a Control Morpho-
lino (Control MO) were purchased from Gene Tools LLC,
USA.
Full length coding sequences for Xenopus alk3, alk6,
and msx2 were amplified from a stage 11–17 cDNA pool
and cloned into the pCRII TA vector (ThermoFisher Sci-
entific, USA). For cloning of the Flag-tagged full-length
Xenopus ALK3 and ALK6 (ALK3-Flag and ALK6-Flag),
the coding sequences of Xenopus alk3 and alk6 were
subcloned into the EcoRI and XhoI sites of a pCS2+
vector [103] in frame with a Flag-tag. The 5′ UTRs of
alk3 and alk6 were similarly amplified and cloned into
the pCS2+ vector 5′ of an egfp coding sequence. The
full-length sequence of the alk6 mRNA has been sub-
mitted to Genebank (BankIt1812091 Xenopus,
KR052160). The in situ probes for chordin, sox2 and
twist were kind gifts of E. DeRobertis and Doris
Wedlich.
The following commercial antibodies were used: rabbit
anti-GFP (Abcam, UK) and mouse anti-GAPDH (Protein-
tech Group, Inc., USA). Secondary antibodies were anti-
mouse-Alkaline Phosphatase and anti-rabbit-Alkaline
Phosphatase (Cell Signaling Technology, Inc. USA).
Xenopus laevis embryos and microinjection
Xenopus embryos were generated and cultured according
to general protocols and staged according to the normal
table of Nieuwkoop and Faber [55]. All procedures were
performed according to the German animal use and care
law (Tierschutzgesetz) and approved by the local author-
ities and committees (animal care and housing approval:
I/39/EE006, Veterinäramt Erlangen; animal experiments
approval: 54–2532.2–8/08, German state administration
Bavaria/Regierung von Mittelfranken).
RNA for microinjection was prepared using the mMes-
sage mMachine Kit (ThermoFisher Scientific, USA). The
following amounts were injected: 500 pg for alk3–5′-gfp
and alk6–5′-gfp, 50 pg of alk3-flag and alk6-flag RNA;
25 pg of pCS2 alk3-flag and pCS2 alk6-flag DNA and
100 pg of pCS2-β-galactosidase DNA. Knock-down was
achieved by injection of 0.8 pmol or 1.6 pmol of ALK3
MO and ALK6 MO as indicated.
Embryos were injected and cultured until they reached
the desired stage as indicated.
For subsequent in situ hybridization, single side injec-
tions were performed and traced by co-injection of
pCS2-β-galactosidase DNA. The injected side was visu-
alized by ß-galactosidase staining and in situ hybridiza-
tions were carried out, as described by Harland [104],
using chordin [77], sox2 [105], twist [106], msx2, alk3,
alk6 or bmpr2 as antisense probes, respectively.
RT-PCR
Total RNA was extracted from Xenopus embryos of
the indicated developmental stages (High Pure RNA
Isolation Kit, Roche, Germany), reverse transcribed
using MMLV reverse transcriptase (New England Biolabs,
USA) and the indicated transcripts were amplified
from the resulting cDNA using OneTaq Polymerase
(New England Biolabs, USA). Primer sequences are
provided in Additional file 8: Table S1. For quantifica-
tion of transcription levels of alk3 and alk6, real-time
RT-PCR was carried out using Brilliant III Sybr Green
Master Mix and the Agilent AriaMX Real Time PCR
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system (Agilent Technologies, USA). Transcription
levels of alk3 and alk6 were calculated using synthetic
alk3 and alk6 cDNA as external standard.
Preparation of embryo lysates and western blotting
Embryos were lysed in Lysis buffer (20 mM HEPES
pH 7.9, 200 mM KCl, 0.5 mM DTT, 0.5 mM EDTA,
0.5 % NP–40, 20 % Glycerol) supplemented with
complete Protease Inhibitor and PhosStop Phosphatase
Inhibitor Cocktails (Roche, Germany) at 4 °C. Lysates
were cleared at 16,000 × g for 10 min, and the protein
concentration was determined using a BCA Assay, ac-
cording to the manufacturer’s instructions (Applichem,
Germany). For Western blotting, proteins were sepa-
rated in 10 % polyacrylamid gels [107] and transferred to
PVDF membranes; the desired proteins were then visu-
alized by incubation with the appropriate antibodies and
colorimetric detection using NBT/BCIP.
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